← SynDRA
Larazotide
SynDRA canonical compound SYN1972369 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HP | TJP1 |
|---|
| Mechanism of action | tight junction regulator |
|---|
All known targets
Mechanisms of action (all sources)
- CHRNB4 PARTIAL AGONIST
- Neuronal acetylcholine receptor; alpha3/beta4 partial agonist
- CHRNA3 PARTIAL AGONIST
- tight junction regulator
- Modulator
Cross-references
Synonyms
- Larazotida
- Larazotide [USAN:INN]
- AT 2347
- ZN3R5560ZV
- larazotidum
- Larazotide [INN]
- RefChem:798506
- LARAZOTIDE [USAN]
- LARAZOTIDE [WHO-DD]
- DTXCID70103017
- AT-1001
- UNII-ZN3R5560ZV
- Larazotide Acetate
- Larazotide (USAN/INN)
- orb1989211
- SCHEMBL23668120
- GTPL13724
- CHEBI:177799
- ORFLZNAGUTZRLQ-ZMBVWFSWSA-N
- AT1001
- AT2347
- AKOS040741937
- T15711L
- H-Gly-Gly-Val-Leu-Val-Gln-Pro-Gly-OH
- DA-54793
- HY-106268
- CS-0025478
- NS00072884
- D09351
- H57704
- AT-2347
- AKOS040741936
- F77451
- BS-44707
- AT 1001
- D09352
- Larazotide acetate (USAN)
- Glycine, glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-, monoacetate
- UNII-FO8S2IW40N
Look up Larazotide in the interactive SynDRA portal →